» Articles » PMID: 33598475

Effects of Saffron Extract Supplementation on Mood, Well-Being, and Response to a Psychosocial Stressor in Healthy Adults: A Randomized, Double-Blind, Parallel Group, Clinical Trial

Abstract

Anxiety, stress, and low mood are closely related and may contribute to depressive symptoms. Among non-pharmacological solutions to improve subclinical mood symptoms and resilience to stress, natural products such as saffron-identified as promising following preliminary beneficial effects in major depressive disorder-represent a relevant strategy. This study aimed to assess the efficacy of 8 weeks' supplementation with 30 mg standardized saffron extract on emotional well-being in healthy adults with subclinical feelings of low mood and anxiety and/or stress and evaluate the acute effect of saffron in response to a lab-based psychosocial stressor. The study adopted a double-blind, randomized, parallel groups design in which 56 healthy male and female individuals (18-54 years) received either a saffron extract or a placebo for 8 weeks. Chronic effects of saffron on subjective anxiety, stress, and depressive feelings were assessed using a questionnaire battery [including Profile of Mood State-2, (POMS)] and acute effects in response to a lab-based psychosocial stressor were measured through psychological and physiological parameters. Urinary crocetin levels were quantified. Participants who received the saffron extract reported reduced depression scores and improved social relationships at the end of the study. Urinary crocetin levels increased significantly with saffron supplementation and were correlated with change in depression scores. The typical stress-induced decrease in heart rate variability (HRV) during exposure to the stressor was attenuated following acute saffron intake. Saffron extract appears to improve subclinical depressive symptoms in healthy individuals and may contribute to increased resilience against the development of stress-related psychiatric disorders. NCT03639831.

Citing Articles

Exploring the Potential of Saffron as a Therapeutic Agent in Depression Treatment: A Comparative Review.

Chauhan S, Tiwari A, Verma A, Padhan P, Verma S, Gupta P Yale J Biol Med. 2024; 97(3):365-381.

PMID: 39351321 PMC: 11426294. DOI: 10.59249/XURF4540.


Plant extracts and omega-3 supplementation modulate hippocampal oxylipin profile in response to LPS-induced neuroinflammation.

Martin M, Debenay E, Bardinet J, Peltier A, Pourtau L, Gaudout D Inflamm Res. 2024; 73(11):2023-2042.

PMID: 39340661 PMC: 11541341. DOI: 10.1007/s00011-024-01947-9.


(Saffron): A potential multifunctional therapeutic agent for neurodegenerative disorders.

Khazdair M J Biomed Res. 2024; 39(1):114-116.

PMID: 39148255 PMC: 11873588. DOI: 10.7555/JBR.38.20240131.


Oral supplementation with crocin (a constituent of saffron) in subjects with cigarette smoking: a clinical trial.

Mahdavi M, Ghaderi A, Hazegh P, Baseri M, Vahed N, Nazemi S Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(8):5689-5699.

PMID: 38294505 DOI: 10.1007/s00210-024-02970-7.


Necroptosis in Pneumonia: Therapeutic Strategies and Future Perspectives.

Mei X, Zhang Y, Wang S, Wang H, Chen R, Ma K Viruses. 2024; 16(1).

PMID: 38257794 PMC: 10818625. DOI: 10.3390/v16010094.


References
1.
Gorman J, Sloan R . Heart rate variability in depressive and anxiety disorders. Am Heart J. 2000; 140(4 Suppl):77-83. DOI: 10.1067/mhj.2000.109981. View

2.
Meyer T, Miller M, Metzger R, Borkovec T . Development and validation of the Penn State Worry Questionnaire. Behav Res Ther. 1990; 28(6):487-95. DOI: 10.1016/0005-7967(90)90135-6. View

3.
Brouns F, Bjorck I, Frayn K, Gibbs A, Lang V, Slama G . Glycaemic index methodology. Nutr Res Rev. 2008; 18(1):145-71. DOI: 10.1079/NRR2005100. View

4.
Kell G, Rao A, Beccaria G, Clayton P, Inarejos-Garcia A, Prodanov M . affron a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial. Complement Ther Med. 2017; 33:58-64. DOI: 10.1016/j.ctim.2017.06.001. View

5.
Hosseinzadeh H, Sadeghnia H . Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systems. Phytomedicine. 2006; 14(4):256-62. DOI: 10.1016/j.phymed.2006.03.007. View